⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
APhA announces 2026 Immunization Champion Award winners
prnewswire.com
PFE
MRK
MRNA
SNY
Life Sciences Analytics Market Advances to US$ 23.17 Billion by 2033 on AI-Driven Drug Discovery and Cloud Platforms Says Astute Analytica
globenewswire.com
JNJ
AZN
MRK
ORCL
IQV
PFE
NVS
TAK
BMY
SNY
LLY
GILD
ACN
DLTR
IBM
QuantX Biosciences Closes Oversubscribed $85M Series B Financing
globenewswire.com
SNY
Press Release: Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia
globenewswire.com
SNY
Coxsackievirus Infections Market Research Report 2025-2035: High Burden of Pediatric and Neonatal Infections, Link to Type 1 Diabetes Risk, Advances in Vaccine Development Driving Expansion
globenewswire.com
SNY
SVA
Cancer Immunotherapy Research Report 2026: Market Forecasts 2025-2029 for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer with Executive and Consultant Guides
globenewswire.com
ABBV
ADAG
ADAP
ACET
ALXO
AMBR
AMGN
RCUS
AZN
ATRC
BBLU
BIIB
BNTX
BOLT
BMY
CRBU
CLDX
CRVS
LLY
EVAX
GNSS
GILD
GLSI
IMUX
IMMX
IMNM
INCY
INDP
ISRL
IOBT
JNJ
MRK
MRNA
MBIO
NVS
NVX
PDSB
PFE
REGN
SNY
SNT
URGN
ZYME
Sobi to Showcase Scientific advances and Commitment to the Haemophilia community at EAHAD 2026
prnewswire.com
SNY
Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion
globenewswire.com
SNY
Quantum Secure Communication Market to Reach US$ 1,861.78 Million by 2035 Driven by Capital Inflows, Government Initiatives, and Telecom Network Adoption Says Astute Analytica
globenewswire.com
GOOG
JPM
VZ
T
TM
NTES
CHTR
ARQQ
KT
SKM
TSLA
MSFT
AMZN
NVDA
IBM
QCOM
INTC
CSCO
ORCL
CRM
ACN
ADP
FIS
PYPL
COIN
MU
ADI
NXPI
ON
QTRX
AEHR
MCHP
SWKS
QRVO
AVGO
MRVL
AMD
IONQ
RIG
CRIS
EDIT
NTLA
ALNY
BIIB
GILD
REGN
AMGN
BMY
PFE
MRK
ABBV
LLY
SNY
AZN
NVS
XOM
CVX
SHEL
BABA
JD
PDD
BIDU
IQ
VIPS
NIO
LI
XPEV
RIVN
LCID
F
GM
STLA
HMC
SONY
HPQ
DELL
HPE
Press Release: Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher disease
globenewswire.com
SNY